Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-028625
Filing Date
2014-08-07
Accepted
2014-08-07 20:58:46
Documents
1
Period of Report
2014-07-10

Document Format Files

Seq Description Document Type Size
1 rrd414222.html 4  
1 rrd414222.xml 4 5441
  Complete submission text file 0001181431-14-028625.txt   6982
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Issuer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address
FEKETE MICHAEL (Reporting) CIK: 0001581383 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35144 | Film No.: 141025421